The hospice moratorium may be temporary—but the changes it signals for hospice oversight could be permanent.
In Part One of The Hospice Moratorium: What CMS Is Really Signaling About the Future, Chris Comeaux and Cordt Kassner, PhD, are joined by Dr. Jennifer Kennedy, Vice President for Quality, Standards and Compliance at CHAP, to unpack why CMS implemented the hospice moratorium and what it could mean for the future of the Medicare hospice benefit.
The conversation explores the growing federal focus on fraud and abuse, rapid hospice market expansion, Medicare enrollment, accreditation oversight, and increasingly sophisticated screening of providers. Jennifer also explains why she believes the moratorium could be extended—and why CMS scrutiny is unlikely to disappear when the moratorium eventually ends.
But there’s another side to the crackdown: legitimate hospice providers can get caught in the same regulatory net designed to stop bad actors. What happens when high-quality organizations want to expand into rural or underserved communities but can’t? And can CMS become precise enough to protect access while aggressively pursuing fraud?
In this episode:
- What the CMS hospice moratorium actually means
- Why fraud and rapid market expansion triggered increased scrutiny
- Whether the moratorium could be extended
- The role of accreditation and enrollment screening
- How legitimate hospice providers may be unintentionally affected
- Why quality and compliance will define the next era of hospice oversight
Guest: Dr. Jennifer Kennedy,
Co-Host: Cordt Kassner, PHD, Publisher, Hospice & Palliative Care Today
Host: Chris Comeaux, President / CEO of Teleios, author of The Anatomy of Leadership
Teleios Collaborative Network / https://www.teleioscn.org/tcntalkspodcast
More episodes from "TCN Talks"



Don't miss an episode of “TCN Talks” and subscribe to it in the GetPodcast app.








